In vitro characterization of polyorthoester microparticles containing bupivacaine

被引：18

作者：

Deng, JS ^{[1
]}

Li, L ^{[1
]}

Tian, YQ ^{[1
]}

Ginsburg, E ^{[1
]}

Widman, M ^{[1
]}

Myers, A ^{[1
]}

机构：

[1] Abbott Labs, Hosp Prod Div, Adv Drug Delivery, Abbott Pk, IL 60064 USA

来源：

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY | 2003年 / 8卷 / 01期

关键词：

spray congealing; injectable microparticles; polyorthoester; bupivacaine; particle size; syringeability; injectability; in vitro drug release; initial burst-drug release; long acting;

D O I：

10.1081/PDT-120017521

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Laboratory-scale spray-congealing equipment was utilized to fabricate injectable microparticles consisting of polyorthoester and bupivacame. Operating conditions for the spray-congealing process were optimized to produce microparticles with the desired shape and particle size to yield acceptable syringeability and injectability. Characterizations were performed to determine the chemico-physical properties of polyorthoester before and after microparticle fabrication. Microparticles with different drug loadings and comparable particle sizes were produced, and their in vitro drug-release profiles were determined. The in vitro drug release of microparticles with a high drug loading was markedly faster than those with a low drug loading. This is partially attributed to a more significant initial burst-drug release of the microparticles with a high drug loading. The microparticles have demonstrated the potential to be used for long-acting postsurgery pain management by local injection.

引用

页码：31 / 38

页数：8

共 24 条

[1]

BERDE CB, 1997, Patent No. 5618563

[2]

BERDE CB, 1999, Patent No. 5922340

[3]

BERDE CB, 2000, Patent No. 6046187

[4]

BERDE CB, 1997, Patent No. 5700485

[5] BIOCOMPATIBILITY OF A NEW SEMISOLID BIOERODIBLE POLY(ORTHO ESTER) INTENDED FOR THE OCULAR DELIVERY OF 5-FLUOROURACIL [J].

BERNATCHEZ, SF ;

MERKLI, A ;

MINH, TL ;

TABATABAY, C ;

ANDERSON, JM ;

GURNY, R .

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1994, 28 (09) :1037-1046

[6] BIOTOLERANCE OF A SEMISOLID HYDROPHOBIC BIODEGRADABLE POLY(ORTHO ESTER) FOR CONTROLLED DRUG DELIVERY [J].

BERNATCHEZ, SF ;

MERKLI, A ;

TABATABAY, C ;

GURNY, R ;

ZHAO, QH ;

ANDERSON, JM ;

HELLER, J .

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1993, 27 (05) :677-681

[7] Auto-catalyzed poly(ortho ester) microspheres: a study of their erosion and drug release mechanism [J].

Chia, HH ;

Yang, YY ;

Chung, TS ;

Ng, S ;

Heller, J .

JOURNAL OF CONTROLLED RELEASE, 2001, 75 (1-2) :11-25

[8] Controlled release of tobramycin sulfate from poly(ortho esters) implantable discs for the treatment of osteomyelitis [J].

Du, J ;

Jasti, B ;

Vasavada, RC .

JOURNAL OF CONTROLLED RELEASE, 1997, 43 (2-3) :223-233

[9]

GOLDENHEIM P, 1999, Patent No. 990114

[10] Poly(ortho esters) - their development and some recent applications [J].

Heller, J ;

Barr, J ;

Ng, SY ;

Shen, HR ;

Schwach-Abdellaoui, K ;

Emmahl, S ;

Rothen-Weinhold, A ;

Gurny, R .

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) :121-128

← 1 2 3 →